Rapaport, Mark Hyman

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 2,964

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 1,683

Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

Mullins, N., Forstner, A. J., O’Connell, K. S., Coombes, B., Coleman, J. R. I., Qiao, Z., Als, T. D., Bigdeli, T. B., Børte, S., Bryois, J., et al. (2021) · Nature Genetics

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 1,517

Rare coding variants in ten genes confer substantial risk for schizophrenia

Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 983

Quality-of-Life Impairment in Depressive and Anxiety Disorders

Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005) · American Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 914

Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population

Judd, L. L., Paulus, M. P., Wells, K. B., & Rapaport, M. H. (1996) · American Journal of Psychiatry

Mental Health Treatment and AccessTreatment of Major Depression

Cited by 538

Quality of life: The ultimate outcome measure of interventions in major depressive disorder

IsHak, W. W., Greenberg, J. M., Balayan, K., Kapitanski, N., Jeffrey, J., Fathy, H., Fakhry, H., & Rapaport, M. H. (2011) · Harvard Review of Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 313

Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

Mullins, N., Kang, J., Campos, A. I., Coleman, J. R. I., Edwards, A. C., Galfalvy, H., Levey, D. F., Lori, A., Shabalin, A., Starnawska, A., et al. (2022) · Biological Psychiatry

Suicide and Self-Harm StudiesGenetic Associations and Epidemiology

Cited by 238

Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment

Rapaport, M. (1998) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 163

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012) · Journal of Clinical Psychopharmacology

Fatty Acid Research and HealthTreatment of Major Depression

Cited by 162

Effects of the acute administration of caffeine in patients with schizophrenia

Lucas, P. B., Pickar, D., Kelsoe, J., Rapaport, M., Pato, C., & Hommer, D. (1990) · Biological Psychiatry

Schizophrenia research and treatmentCoffee research and impacts

Cited by 125

Escitalopram continuation treatment prevents relapse of depressive episodes

Rapaport, M. H., Bose, A., & Zheng, H. (2004) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 121

Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies

Griffiths, C. E. M., Fava, M., Miller, A. H., Russell, J., Ball, S. G., Xu, W., Acharya, N., & Rapaport, M. H. (2017) · Psychotherapy and Psychosomatics

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 115

A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial

Gillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry

Sleep and related disordersTreatment of Major Depression

Cited by 104

Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood

Bhatti, T., Gillin, J. C., Seifritz, E., Moore, P., Clark, C., Golshan, S., Stahl, S., Rapaport, M., & Kelsoe, J. (1998) · Biological Psychiatry

Sleep and Wakefulness ResearchTryptophan and brain disorders

Cited by 85

Sleep and sleep electroencephalogram in depressed patients treated with phenelzine

Landolt, H.-P., Raimo, E. B., Schnierow, B. J., Kelsoe, J. R., Rapaport, M. H., & Gillin, J. C. (2001) · Archives of General Psychiatry

Sleep and Wakefulness ResearchTreatment of Major Depression

Cited by 82

Sertraline treatment of panic disorder: results of a long-term study

Rapaport, M. H., Wolkow, R., Rubin, A., Hackett, E., Pollack, M., & Ota, K. Y. (2001) · Acta Psychiatrica Scandinavica

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 79

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial

Mischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., et al. (2022) · The Journal of Clinical Psychiatry

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 56

Treatment of functional neurological disorder: current state, future directions, and a research agenda

LaFaver, K., LaFrance, W. C., Price, M. E., Rosen, P. B., & Rapaport, M. (2021) · CNS Spectrums

Psychosomatic Disorders and Their TreatmentsCardiovascular Syncope and Autonomic Disorders

Cited by 48

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial

Rush, A. J., Marangell, L. B., Sackeim, H. A., George, M. S., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Rittberg, B. R., Burke, W. J., et al. (2005) · Biological Psychiatry

Vagus Nerve Stimulation ResearchDeep Brain Stimulation and Movement Disorders

Cited by 44

Circulating Lymphocyte Phenotypic Surface Markers in Anxiety Disorder Patients and Normal Volunteers

Rapaport, M. H. (1998) · Biological Psychiatry

Stress Responses and CortisolAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 43

Serum cytokine and soluble interleukin‐2 receptors in patients with panic disorder

Rapaport, M. H., & Stein, M. B. (1994) · Anxiety

Tryptophan and brain disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 41

Quality of Life Impairment in Anxiety Disorders

Koury, M. A., & Rapaport, M. H. (2007) · Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 10